Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN112483 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tenascin C (TNC) antibody
- Antibody type
- Monoclonal
- Description
- Affinity Chromatography on Protein A.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- T2H5
- Vial size
- 0.1 mg
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Immunohistochemical localization of collagen type III and type IV, laminin, tenascin and alpha-smooth muscle actin (alphaSMA) in the human liver in peliosis.
Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast.
Gulubova M
Pathology, research and practice 2002;198(12):803-12
Pathology, research and practice 2002;198(12):803-12
Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Faustino AM, van Garderen E, Schalken JA, Nederbragt H
Journal of comparative pathology 2002 Jan;126(1):1-8
Journal of comparative pathology 2002 Jan;126(1):1-8
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
Ioachim E, Charchanti A, Briasoulis E, Karavasilis V, Tsanou H, Arvanitis DL, Agnantis NJ, Pavlidis N
European journal of cancer (Oxford, England : 1990) 2002 Dec;38(18):2362-70
European journal of cancer (Oxford, England : 1990) 2002 Dec;38(18):2362-70
Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast.
Tökés AM, Hortoványi E, Csordás G, Kulka J, Mózes G, Hatalyák A, Kádár A
Anticancer research 1999 Jan-Feb;19(1A):175-9
Anticancer research 1999 Jan-Feb;19(1A):175-9
No comments: Submit comment
No validations: Submit validation data